COMMUNIQUÉS West-GlobeNewswire

Johanna Ivaska has been appointed Head & Vice President of Oncology Research in Orion Corporation
10/09/2018
ORION CORPORATION PRESS RELEASE 10 SEPTEMBER 2018 Johanna Ivaska has been appointed Head & Vice President of Oncology Research in Orion Corporation Johanna Ivaska (born 1972), Academy Professor of Biochemistry has [...]
Solon Eiendom ASA - Primary insider notification
10/09/2018
(Oslo, Norway, September 07, 2018) Solon Eiendom ASA Chairman of the Board Simen Thorsen has today through his wholly owned company Hortulan AS acquired 5,650 shares in Solon Eiendom ASA at a price of NOK 29.0211 per [...]
Xbrane Biopharma announces product portfolio update with a new full strategic focus on biosimilars
10/09/2018
Press release 2018-09-10 The board of directors of Xbrane Biopharma (publ.) ("Xbrane" or the Company) has decided to shift strategic focus in the Company's product pipeline to biosimilars. As Xbranes leading biosimilar [...]
A new big discovery from the Bio-on laboratories: also from the used cooking oil comes the bioplastic
10/09/2018
Waste oil is added to the "raw materials" already used to produce Bio-on bioplastic: beet molasses and sugar cane, fruit and potato wastes, carbohydrates in general and crude glycerol. A new discovery that transforms a [...]
Shire plc: Elections for the interim dividend in respect of the six months to June 30, 2018
10/09/2018
Elections for the interim dividend in respect of the six months to June 30, 2018 September 10, 2018 - Shire plc (LSE: SHP, NASDAQ: SHPG) (the “Company”) announced on July 31, 2018, an interim dividend of 5.60 US cents [...]
Oxurion NV Announces New NYSE Euronext Brussels Stock Ticker "OXUR" and Launch of New Websit
10/09/2018
Oxurion NV trading under "OXUR" on NYSE Euronext Brussels Oxurion NV launches new global website showcasing its comprehensive drug development approach and diverse portfolio of next-generation therapies for back of the [...]
Sensorion to Partner with Vestibular Disorders Association (VeDA) in Sponsorship of Balance Awareness Week 2018 for Vestibular Disorders
10/09/2018
MONTPELLIER, France, Sept. 10, 2018 (GLOBE NEWSWIRE) -- Sensorion ( FR 0012596468 – ALSEN ), a biotech company specializing in the treatment of inner ear diseases, today announces that it has joined with the Vestibular [...]
Innate Pharma announces data presentations at upcoming scientific meetings
10/09/2018
Innate Pharma announces data presentations at upcoming scientific meetings Updated long term follow-up data and new data from cohort expansion in the Phase I of IPH4102 in advanced CTCL at the EORTC CLTF 2018 Meeting [...]
Innate Pharma annonce la présentation de données lors de prochains congrès scientifiques
10/09/2018
INNATE PHARMA ANNONCE LA PRÉSENTATION DE DONNÉES LORS DE PROCHAINS CONGRÈS SCIENTIFIQUES Données de suivi à long terme et premières données de l'extension de cohorte pour la Phase I d'IPH4102 dans les lymphomes T [...]
NeuroSearch A/S receives notice of payment from Teva Pharmaceutical International GmbH regarding Pridopidine and changes financial outlook for 2018
08/09/2018
Company Announcement 8 September 2018 On 16 May 2018, NeuroSearch A/S ("NeuroSearch") entered into an agreement with, among others, Teva Pharmaceutical International GmbH ("Teva") (the "Agreement") to release Teva from [...]
Golden Leaf Holdings Refiles Amended and Restated MD&A
07/09/2018
TORONTO, Sept. 07, 2018 (GLOBE NEWSWIRE) -- Golden Leaf Holdings Ltd. (“GLH” or the “Company”) (CSE:GLH) (OTCQB:GLDFF), a cannabis company with cultivation, production and retail operations built around recognized [...]
Kalytera Announces Next Payment of Invoices in Shares under Payments Agreements with Salzman Group
07/09/2018
SAN FRANCISCO and TEL AVIV, Israel, Sept. 07, 2018 (GLOBE NEWSWIRE) -- Kalytera Therapeutics, Inc. (TSX VENTURE: KALY and OTCQB: KALTF) (the " Company " or " Kalytera ") today announced that the Company has elected to [...]
Flexion Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
07/09/2018
BURLINGTON, Mass., Sept. 07, 2018 (GLOBE NEWSWIRE) -- Flexion Therapeutics, Inc. (Nasdaq:FLXN) today announced a grant of inducement stock options to four new employees for an aggregate of 10,500 shares of common stock [...]
iKang Announces Buyer Group’s Re-Evaluation of Merger and Request for Extension of Termination Date
07/09/2018
BEIJING, Sept. 07, 2018 (GLOBE NEWSWIRE) -- iKang Healthcare Group, Inc. (“iKang” or the “Company”) (Nasdaq: KANG), a major provider in China’s fast growing private preventive healthcare services market, today announced [...]
GBT Announces Participation at the 2018 Morgan Stanley Global Healthcare Conference
07/09/2018
SOUTH SAN FRANCISCO, Calif., Sept. 07, 2018 (GLOBE NEWSWIRE) -- Global Blood Therapeutics, Inc. (GBT) (NASDAQ: GBT) today announced that it will present at the 2018 Morgan Stanley Global Healthcare Conference in New [...]
Burcon Announces Results of Shareholder Meeting
07/09/2018
VANCOUVER, British Columbia, Sept. 07, 2018 (GLOBE NEWSWIRE) -- Burcon NutraScience Corporation (TSX: BU) a leader in functional, renewable plant-based proteins, is pleased to announce the results from its 2018 annual [...]
National Brain Tumor Society Issues Tip Sheet on Pediatric Brain Cancer for Childhood Cancer Awareness Month
07/09/2018
Newton, MA , Sept. 07, 2018 (GLOBE NEWSWIRE) -- September is national Childhood Cancer Awareness Month, and given brain tumors are the second most common group of childhood cancers and the leading cause of cancer deaths [...]
UPDATE -- Golden Leaf Holdings Adds Chief Marketing and Sales Officer to Business Development Team
07/09/2018
Jeff Yapp joins as Chief Marketing and Sales Officer to bolster business development team and strengthen Company’s brand recognition and customer relations TORONTO, Sept. 07, 2018 (GLOBE NEWSWIRE) -- Golden Leaf [...]
Adaptimmune Therapeutics plc Announces Closing of Registered Direct Offering of American Depositary Shares
07/09/2018
PHILADELPHIA, Pa. and OXFORD, U.K., Sept. 07, 2018 (GLOBE NEWSWIRE) -- Adaptimmune Therapeutics plc (“Adaptimmune”) (Nasdaq: ADAP), a leader in T-cell therapy to treat cancer, today announced the closing of its [...]

Pages